Pebblebrook Hotel Trust PEB

NYSE Price as of Nov 17, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$21.75
$10.46
$22.40
Market cap
$2.43B
P/E (GAAP, TTM)
—
P/E (operating)
70.21
Dividend yield
0.2%
Revenue growth YoY
1.0%
EPS growth YoY
-51.4%
ROIC
0.8%
Piotroski F-score
4

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
70.21

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ Year agoChange YoY
Revenue growth YoY (qtr) -0.1% 7.9%-8.0 pts ——
EPS growth YoY (qtr) 183.3% 29.7%+153.6 pts ——
Revenue growth (TTM) 2.1% 2.8%-0.8 pts ——
EPS growth (TTM) -25.9% -79.5%+53.6 pts ——
P/E (GAAP, TTM) — —— ——
P/E (operating) 63.49 65.65-2.16 ——
P/E (excl. gains) — —— ——
P/B 0.89 0.92-0.03 ——
ROIC 0.8% 0.8%0.0 pts ——
Net margin -4.5% -4.5%0.0 pts ——
Dividend yield 0.2% 0.2%0.0 pts ——
EPS (TTM) -0.68 -0.79+13.9% ——
Price $18.77 $19.41-3.3% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $402.75M -1.1% 1.0% -0.56 -429.4% -51.4% -13.6%
Jun 30, 2026 $407.14M 17.8% -0.1% 0.17 165.4% 183.3% 5.8%
Mar 31, 2026 $345.66M -1.0% 7.9% -0.26 -18.2% 29.7% -5.6%
Dec 31, 2025 * $349.02M -12.5% 3.4% -0.22 40.5% 53.2% -5.1%
Sep 30, 2025 $398.72M -2.2% -1.4% -0.37 -716.7% -254.2% -8.3%
Jun 30, 2025 $407.54M 27.2% 2.6% 0.06 116.2% -62.5% 4.4%
Mar 31, 2025 $320.27M -5.1% 2.0% -0.37 21.3% -15.6% -10.3%
Dec 31, 2024 * $337.60M -16.5% 1.1% -0.47 -295.8% -42.4% -15.0%
Sep 30, 2024 $404.53M 1.9% 2.2% 0.24 50.0% 142.1% 10.8%
Jun 30, 2024 $397.11M 26.4% 3.3% 0.16 150.0% -33.3% 7.8%
Mar 31, 2024 $314.07M -6.0% 2.7% -0.32 3.0% -18.5% -9.0%
Dec 31, 2023 * $334.09M -15.6% 4.5% -0.33 42.1% -3.1% -12.8%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 17, 2026 Date of the latest closing price used.
Price $21.75 Latest closing price.
Market cap $2.43B Price × shares outstanding.
Enterprise value $4.37B Market cap + debt − cash: the price of the whole business.
Shares 111.69M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) 70.21 Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) 66.09 Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -2.7% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -4.0% TTM EPS ÷ price.
P/B 0.98 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 1.65 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 1.61 Market cap ÷ revenue of the last four quarters.
P/FCF 9.73 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA 99.76 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT 99.76 Enterprise value ÷ operating income.
EV/Sales 2.96 Enterprise value ÷ revenue.
Book value / share 22.10 Shareholders' equity ÷ shares.
FCF yield 10.3% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS 0.31 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income -$99.74M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $402.75M Revenue of the latest reported quarter.
Net income (qtr) -$54.97M Net income of the latest reported quarter.
EPS (qtr) -0.56 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 1.0% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) -1.1% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -51.4% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) -429.4% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -66.2% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) -333.1% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -6.9% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -13.6% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $1.50B Revenue of the last four quarters.
Net income (TTM) -$68.52M Net income of the last four quarters.
EPS (TTM) -0.87 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 2.8% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 24.3% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 30.4% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.2% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) $0.0400 Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 1.9% Dividends ÷ free cash flow.
Dividend growth (1y) 0.0% Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) 0.0% Annualised dividend growth over 3 years.
Dividend CAGR (5y) 0.0% Annualised dividend growth over 5 years.
Payments (12m) 4 Number of dividend payments in the last 12 months.
Last ex-dividend date Sep 30, 2026 Most recent ex-dividend date.
Buyback yield 3.0% Share repurchases ÷ market cap.
Shareholder yield 3.2% Dividend yield + buyback yield.
Profitability
Gross margin — Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 3.0% EBITDA ÷ revenue.
Operating margin 3.0% Operating income ÷ revenue.
Net margin -4.5% Net income ÷ revenue.
FCF margin 16.9% Free cash flow ÷ revenue.
ROE -2.7% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -1.2% Return on assets: net income ÷ total assets.
ROIC 0.8% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 1.5% Latest fiscal year revenue vs the year before.
Net income growth (annual) -1,451.4% Latest fiscal year net income vs the year before.
EPS growth (annual) -130.8% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 2.0% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio — Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio — (Current assets − inventory) ÷ current liabilities.
Cash ratio — Cash ÷ current liabilities.
Debt / equity 0.86 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.40 Total debt ÷ total assets.
Debt / EBITDA 48.50 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA 44.29 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage 0.42 Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -5.9% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 0.9% Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.28 Revenue ÷ total assets.
Days sales outstanding — Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables — Average days to pay suppliers.
Trading & momentum
52-week high $22.40 Highest price in the last 52 weeks.
52-week low $10.46 Lowest price in the last 52 weeks.
From 52-week high -2.9% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 107.9% How far above the 52-week low the price is.
Avg volume (30d) 1.75M Average shares traded per day over the last 30 days.
Avg $ volume (30d) $37.34M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 4 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score — Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $1.48B Revenue of the latest fiscal year.
Net income -$65.81M Net income of the latest fiscal year.
Diluted EPS -0.90 Diluted earnings per share of the latest fiscal year.
EBITDA $43.80M Operating income + depreciation & amortization.
Free cash flow $249.73M Operating cash flow − capital spending.
Total debt $2.12B Long-term plus current debt.
Cash $184.19M Cash and equivalents.
Equity $2.47B Shareholders' equity.
Total assets $5.35B Total assets.